{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:35:37Z","timestamp":1793140537446,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pnpbp.2024.111221","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T17:01:37Z","timestamp":1734454897000},"page":"111221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Adiponectin, resistin, interleukin-4 and TGF-\u03b22 levels in treatment resistant schizophrenia patients"],"prefix":"10.1016","volume":"136","author":[{"given":"Andreas","family":"Karampas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Leontaritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Markozannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Asimakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra T.","family":"Archimandriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polyxeni","family":"Spyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Plakoutsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kotsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Petrikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111221_bb0005","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111221_bb0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/schbul\/sbaa136","article-title":"High mobility group protein 1 and Dickkopf-related protein 1 in schizophrenia and treatment-resistant schizophrenia: associations with Interleukin-6, symptom domains, and neurocognitive impairments","volume":"47","author":"Al-Dujaili","year":"2021","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111221_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/tropicalmed9010013","article-title":"Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: a comprehensive review","volume":"9","author":"Al-Qahtani","year":"2024","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0025","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0040","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/08923973.2011.651535","article-title":"Clozapine inhibits Th1 cell differentiation and causes the suppression of IFN-\u03b3 production in peripheral blood mononuclear cells","volume":"34","author":"Chen","year":"2012","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0030","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1017\/S0033291721000155","article-title":"Changes in peripheral blood compounds following psychopharmacological treatment in drug-na\u00efve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis","volume":"51","author":"\u00c7akici","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.psychres.2018.07.041","article-title":"The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia","volume":"268","author":"Dahan","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0055","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.3390\/jcm10173849","article-title":"The role of cytokines in the pathogenesis of schizophrenia","volume":"1O","author":"Dawidowski","year":"2021","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111221_bb0060","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1007\/s12035-022-02976-3","article-title":"Linking inflammation, aberrant glutamate-dopamine interaction, and post-synaptic changes: translational relevance for schizophrenia and antipsychotic treatment: a systematic review","volume":"59","author":"De Bartolomeis","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108236","article-title":"Clozapine\u2019s multiple cellular mechanisms: what do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia","volume":"236","author":"De Bartolomeis","year":"2022","journal-title":"Pharmacol.Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111221_bib301","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41537-024-00469-x","article-title":"Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome","volume":"10","author":"Dong","year":"2024","journal-title":"Schizophrenia (Heidelb)"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111221_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/HAB-180344","article-title":"Serum cytokine profile in schizophrenic patients","volume":"27","author":"Eftekharian","year":"2019","journal-title":"Hum. Antibodies"},{"key":"10.1016\/j.pnpbp.2024.111221_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2020.12.020","article-title":"Peripheral immune markers and antipsychotic non-response in psychosis","volume":"230","author":"Enache","year":"2021","journal-title":"Schizophr.Res."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0080","first-page":"1696","article-title":"Ameta-analysis of blood cytokine network alterations in psychiatric patients: comparison between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Biol."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0085","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jpsychires.2011.04.009","article-title":"Impact of antipsychotics on cytokine production in-vitro","volume":"45","author":"Himmerich","year":"2011","journal-title":"J.Psychiatr.Res."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0090","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"1174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111221_bb0095","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.4049\/jimmunol.1302764","article-title":"Human Resistin promotes neutrophil Proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injury","volume":"192","author":"Jiang","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: a systematic literature review","volume":"29","author":"Kennedy","year":"2014","journal-title":"Int.Clin.Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.psychres.2014.04.049","article-title":"Cytokine andadiponectin alterations in patients with schizophrenia treated with clozapine","volume":"218","author":"Klemettila","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psyneuen.2008.08.016","article-title":"Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever","volume":"34","author":"Kluge","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2024.111221_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.regpep.2009.05.002","article-title":"The expression of human Resistin in different leucocyte lineages is modulated by LPS and Tnfa","volume":"157","author":"Kunnari","year":"2009","journal-title":"Regul.Pept."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0120","doi-asserted-by":"crossref","first-page":"sgab012","DOI":"10.1093\/schizbullopen\/sgab012","article-title":"Immune signatures of treatment-resistant schizophrenia: a FondaMental AcademicCenters of expertise in schizophrenia (FACE-SZ) study","volume":"2","author":"Leboyer","year":"2021","journal-title":"Schizophr. Bull. Open"},{"key":"10.1016\/j.pnpbp.2024.111221_bb0130","article-title":"Resistin, a novel host defense peptide of innate immunity","volume":"12","author":"Li","year":"2009","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0135","doi-asserted-by":"crossref","first-page":"2004433","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: From clinical significance to quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111221_bib302","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111221_bb0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11011-013-9433-z","article-title":"N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats","volume":"28","author":"M\u00f6ller","year":"2013","journal-title":"Metab.BrainDis."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0155","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3389\/fpsyt.2019.00892","article-title":"Cytokine alterations in schizophrenia: an updated review","volume":"10","author":"Momtazmanesh","year":"2019","journal-title":"Front.Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111221_bb0160","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/a-0637-1975","article-title":"Correlation between Resistin level and metabolic syndrome component: a review","volume":"50","author":"Mostafazadeh","year":"2018","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41398-021-01764-2","article-title":"Peripheral NF-\u03baB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-\u03baB kinases","volume":"12","author":"Murphy","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111221_bb0170","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/15622975.2015.1062552","article-title":"High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance","volume":"16","author":"Noto","year":"2015","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2014.03.020","article-title":"Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine","volume":"156","author":"O'Connell","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0180","first-page":"85","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Focus Metab. Immunol."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0190","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jpsychires.2023.01.042","article-title":"Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: a systematic review and meta-analysis","volume":"160","author":"Patlola","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0195","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.psychres.2017.07.002","article-title":"Changes in the cytokine profile in first-episode, drug-na\u00efve patients with psychosis after short-term antipsychotic treatment","volume":"256","author":"Petrikis","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2022.110789","article-title":"Adiponectin, leptin and resistin levels in first-episode, drug-na\u00efve patients with psychosis before and after short-term antipsychotic treatment","volume":"157","author":"Petrikis","year":"2022","journal-title":"J.Psychosom. Res."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0205","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/schbul\/sby160","article-title":"A Meta-analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis","volume":"45","author":"Pillinger","year":"2019","journal-title":"Schizophr.Bull."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0210","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ijnp\/pyy062","article-title":"Kinetics of cytokine levels during antipsychotic treatment in schizophrenia: a meta-analysis","volume":"21","author":"Romeo","year":"2018","journal-title":"I. J.Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0220","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41598-024-51932-9","article-title":"Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder","volume":"14","author":"Sarmin","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0225","first-page":"29","article-title":"Role of Resistin in inflammation and inflammation-related diseases","volume":"3","author":"Shanshan","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0230","article-title":"The effect of clozapine on immune-related biomarkers in schizophrenia patients","author":"Shao","year":"2024","journal-title":"B.R.B."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0240","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2008.09.037","article-title":"Immunomodulatory effect of Resistin in human dendritic cells stimulated with Lipoteichoic acid from staphylococcus aureus","volume":"376","author":"Son","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0250","first-page":"59","article-title":"Neuroleptics modulate cytokine andreactive oxygen species production in blood leukocytes of healthy volunteers","volume":"52","author":"Szuster-Ciesielska","year":"2004","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0255","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/mp.2016.90","article-title":"Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review","volume":"2","author":"Tr\u00e9panier","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111221_bb0260","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbrc.2005.07.197","article-title":"Adiponectin induces TNF-a and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli","volume":"335","author":"Tsatsanis","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr.Res."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biopsych.2018.06.015","article-title":"The role of the nuclear factor-\u03baB transcriptional complex in cortical immune activation in schizophrenia","volume":"85","author":"Volk","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111221_bb0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beem.2013.09.003","article-title":"Adiponectin receptors: a review of their structure, function and how they work","volume":"28","author":"Yamauchi","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol.Metab."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0285","article-title":"Catalase and interleukine-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients Asian","volume":"79","author":"Yang","year":"2023","journal-title":"J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111221_bb0290","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00213-022-06067-y","article-title":"Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine","volume":"239","author":"Yuan","year":"2022","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111221_bb0295","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3390\/brainsci12121703","article-title":"Clozapine suppresses the gene expression and the production of cytokines and up-regulates cyclooxygenase 2 mRNA in human Astroglial cells","volume":"12","author":"Yuhas","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.pnpbp.2024.111221_bb0300","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00213-021-05824-9","article-title":"Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders?","volume":"238","author":"Zhao","year":"2021","journal-title":"Psychopharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:28:30Z","timestamp":1745854110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624002896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S0278584624002896"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111221","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adiponectin, resistin, interleukin-4 and TGF-\u03b22 levels in treatment resistant schizophrenia patients","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111221"}}